Article: InnoCentive Doctors Get Prize4Life Awards for ALS Work.

InnoCentive, a web community for open collaboration, and Prize4Life, a non-profit organization dedicated to reaching effective treatments for Amyotrophic Lateral Sclerosis (ALS), announced that prizes totaling $100,000 will be awarded to two InnoCentive Solvers.

Dr. Harvey Arbesman and Dr. Seward Rutkove will receive awards for their accomplishments made while competing for the Prize4Life ALS Biomarker Challenge, which seeks a biomarker for measuring disease progression in ALS.

ALS, commonly known in the US as Lou Gehrig's disease, is a rapidly progressing neurodegenerative disease that typically steals the life of patients within 2-5 years of diagnosis. ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!